BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23679328)

  • 1. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.
    Wang L; Wang Q; Li HL; Han LY
    Asian Pac J Cancer Prev; 2013; 14(3):2113-8. PubMed ID: 23679328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer.
    Reis ST; Pontes-Junior J; Antunes AA; Dall'Oglio MF; Dip N; Passerotti CC; Rossini GA; Morais DR; Nesrallah AJ; Piantino C; Srougi M; Leite KR
    BMC Urol; 2012 May; 12():14. PubMed ID: 22642976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.
    Zhang Y; Cheng S; Zhang G; Ma W; Liu Y; Zhao R; Zhang Q; Pang D
    Cancer Sci; 2012 Jun; 103(6):1084-9. PubMed ID: 22404079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
    Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
    Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
    Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
    Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
    Liu X; Wang W; Chen J; Chen C; Zhou J; Cao L
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):16-21. PubMed ID: 22178867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas.
    Ueda M; Terai Y; Yamashita Y; Kumagai K; Ueki K; Yamaguchi H; Akise D; Hung YC; Ueki M
    Int J Cancer; 2002 Mar; 98(3):335-43. PubMed ID: 11920583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between matrix metalloproteinase 2 and lung cancer progression.
    Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
    Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.
    Wang N; Zhang CQ; He JH; Duan XF; Wang YY; Ji X; Zang WQ; Li M; Ma YY; Wang T; Zhao GQ
    Dig Dis Sci; 2013 Jul; 58(7):1863-70. PubMed ID: 23504349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].
    Qiu G; Fang B; Xin G; Wei Q; Yuan X; Wu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):40-3. PubMed ID: 25575057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [miR-181c promotes the migration and angiogenesis of human A549 cells via targeting inhibition of reversion-inducing cysteine-rich protein with Kazal motifs (RECK)].
    Liu C; Zhao F; Sun P; Han W; Hong M; Wu J; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1084-1090. PubMed ID: 36585230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
    Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.